Primary biliary cholangitis (PBC) is one of those Step 1 liver diseases that feels deceptively simple—until you get a question stem with pruritus, fatigue, a cholestatic lab pattern, and an autoimmune history, and you have to decide between PBC, PSC, drug-induced cholestasis, and extrahepatic obstruction. This post will lock in the definition, pathophys, classic presentation, diagnosis, treatment, and the “Step-style” associations that show up again and again.
Where PBC Fits (Big Picture)
PBC is a chronic autoimmune cholestatic liver disease characterized by progressive destruction of intrahepatic bile ducts, leading to cholestasis, then fibrosis, and potentially cirrhosis and liver failure.
High-yield one-liner
Middle-aged woman + pruritus/fatigue + cholestatic labs + anti-mitochondrial antibodies (AMA) → think PBC.
Definition (Step-friendly)
Primary biliary cholangitis:
- Autoimmune-mediated destruction of small intrahepatic bile ducts
- Causes cholestasis (impaired bile flow) → bile acid accumulation → symptoms
- Slowly progressive; can lead to biliary cirrhosis and portal HTN complications
Key distinction:
- PBC = intrahepatic, small ducts, autoimmune, AMA+
- PSC = intra- and extrahepatic, large ducts, “beading,” p-ANCA, UC association
Pathophysiology (What’s Actually Happening)
Immune mechanism (high-yield)
- Primarily T-cell–mediated autoimmune injury targeting intrahepatic bile ducts
- Hallmark autoantibody: anti-mitochondrial antibody (AMA), classically against E2 subunit of pyruvate dehydrogenase complex (very Step 1-friendly detail)
Consequences of cholestasis
When bile can’t flow:
- Bile acids accumulate → pruritus
- Decreased bile in gut → fat malabsorption
- Reduced absorption of fat-soluble vitamins (A, D, E, K)
- Step tie-in: vitamin D deficiency → osteopenia/osteoporosis
- Reduced bile excretion of cholesterol → hypercholesterolemia and xanthomas/xanthelasmas
Histology buzzwords
- Granulomatous inflammation and destruction of bile ducts
- Classically described as “florid duct lesions” (common board phrasing)
Epidemiology & Risk Factors (What to Recognize in Stems)
Typical patient:
- Woman, often 40–60 years
- Personal or family history of autoimmune disease
Autoimmune associations (high-yield)
PBC commonly coexists with:
- Sjögren syndrome
- Hashimoto thyroiditis
- Systemic sclerosis (CREST)
- Rheumatoid arthritis
- Other autoimmune thyroid disease
(If the stem mentions dry eyes/dry mouth + pruritus + cholestatic labs → your reflex should be PBC.)
Clinical Presentation
Most common symptoms
- Fatigue
- Pruritus (often worse at night; may precede jaundice)
- Jaundice (later)
- RUQ discomfort can occur but is not the hallmark
Physical findings (Step favorites)
- Hepatomegaly (early)
- Hyperpigmentation (can show up in chronic cholestasis)
- Xanthelasmas (yellow plaques on eyelids)
- Xanthomas (cholesterol deposits in skin/tendons)
- Signs of cirrhosis/portal HTN in advanced disease (ascites, varices, splenomegaly)
Complications (board-relevant)
- Cirrhosis → portal HTN → variceal bleeding, ascites
- Fat-soluble vitamin deficiency
- Metabolic bone disease (osteopenia/osteoporosis) due to chronic cholestasis + vitamin D issues
- Increased risk of hepatocellular carcinoma once cirrhosis develops (risk is largely tied to cirrhosis itself)
Diagnosis (How Questions Want You to Prove It)
Step 1 lab pattern: cholestatic
Expect:
- ↑ ALP (disproportionately elevated vs AST/ALT)
- ↑ GGT (supports hepatobiliary source of ALP)
- ↑ direct (conjugated) bilirubin later in disease
- Mild/moderate ↑ AST/ALT can occur, but cholestatic pattern dominates
Serology (classic)
- AMA positive (highly suggestive; often the key test)
- Often ↑ IgM
Imaging (role is mainly exclusion)
- Ultrasound is commonly done to rule out extrahepatic obstruction (stones, tumors). In PBC, ducts are not typically dilated.
Biopsy (when used)
Not always required if labs + antibodies are classic, but may help stage disease or clarify overlap syndromes.
Quick comparison table: PBC vs PSC (high-yield)
| Feature | PBC | PSC |
|---|---|---|
| Typical patient | Middle-aged woman | Middle-aged man |
| Ducts affected | Intrahepatic small ducts | Intra + extrahepatic |
| Antibodies | AMA (anti-mitochondrial) | p-ANCA (often) |
| Association | Autoimmune diseases (Sjögren, scleroderma, thyroid) | UC (strong), IBD |
| Imaging | No “beading” | MRCP/ERCP beading |
| Cancer risk | HCC if cirrhosis | Cholangiocarcinoma (classic), plus HCC if cirrhosis |
Treatment (What Actually Improves Outcomes)
Disease-modifying therapy
- Ursodeoxycholic acid (ursodiol)
- Improves bile flow and slows progression in many patients
- Obeticholic acid (FXR agonist)
- Option if ursodiol inadequate or not tolerated
Symptomatic management (pruritus)
- Cholestyramine (bile acid resin) is classic for cholestatic pruritus
- Step pearl: it binds bile acids in the gut to reduce circulating bile acids
Other supportive care:
- Supplement fat-soluble vitamins as needed (A, D, E, K)
- Screen/treat osteoporosis (DEXA, calcium/vitamin D, bisphosphonates when indicated)
- Manage hyperlipidemia as appropriate (cholestasis can elevate cholesterol, but cardiovascular risk doesn’t always track exactly the same way—focus on what the stem asks)
Definitive therapy for end-stage disease
- Liver transplant for decompensated cirrhosis/liver failure
- Note: PBC can recur post-transplant, but transplant is still highly effective
High-Yield Associations & “Exam Triggers”
The classic Step vignette
- 52-year-old woman
- Pruritus + fatigue
- Elevated ALP and GGT
- Positive AMA
- Maybe history of Sjögren or CREST
- Possible xanthelasmas
“If you see X, think Y”
- Pruritus + cholestatic labs → cholestasis differential (PBC, PSC, obstruction, drug-induced)
- AMA → PBC
- p-ANCA + UC + beading → PSC
- Fat-soluble vitamin deficiency in cholestasis → bleeding tendency (vit K), bone disease (vit D)
First Aid Cross-References (for rapid review)
In First Aid (GI → Liver disorders / cholestatic disease section), PBC is typically listed with these key identifiers:
- Autoimmune destruction of intrahepatic bile ducts
- AMA positive
- Middle-aged woman
- Association with other autoimmune diseases
- Pruritus, jaundice
- Granulomas
- Treat with ursodeoxycholic acid
- (Often contrasted directly with PSC: UC, p-ANCA, beading, cholangiocarcinoma)
Use your FA margin notes to link:
- Cholestasis → ↑ ALP
- Bile acid resins (cholestyramine) → pruritus
- Fat-soluble vitamin deficiency consequences
Rapid Review Checklist (Last-Minute Step 1)
- Definition: autoimmune intrahepatic bile duct destruction → cholestasis
- Patient: woman, 40–60, autoimmune history
- Symptoms: pruritus, fatigue → later jaundice
- Labs: ↑ ALP, ↑ GGT, later ↑ direct bilirubin; often ↑ IgM
- Antibody: AMA (anti-mitochondrial; anti–pyruvate dehydrogenase)
- Histology: granulomas / florid duct lesions
- Tx: ursodiol (± obeticholic acid), cholestyramine for itching, transplant if end-stage
- Don’t confuse with PSC: UC + p-ANCA + beading + cholangiocarcinoma risk